By G HossainPosted on June 4, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical milestones on the horizon. Pharma Tuck-In Deals Grow After a Mediocre First Quarter for Small Biotechs Post navigation Boom, Bust and Recover: What Happens Next as Biotech VC Cycle ResetsGilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market